The Kansas Supreme Court is weighing whether to block a sweeping state law that lets workers easily bypass COVID-19 vaccine ...

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...

Lastly, Pfizer is a solid dividend stock. It now offers a beefy 6.8% yield, and has increased its payouts by 53.6% in the ...

However, in the later stages of the pandemic, demand for the product declined, and Moderna shifted to a loss. For example, ...

It’s important to emphasize that the measles, mumps, and rubella (MMR) vaccine is highly effective—providing 97% protection ...